Document is current
Any future updates will be listed below
-
Authors
Shi, Yangpiaoyi
Tan, Wanhao
Xiao, Yi
Peng, Linglong
Xu, Zhiquan
Liu, Hang
Wei, Qi
Wang, Yaxu
Xiang, Ling
Gu, Haitao
-
Funding
Funding for this research was provided by:
Chongqing Municipal Science and Technology Bureau (CSTB2022NSCQ-MSX1005)
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 15 April 2025
First Online: 3 July 2025
Declarations
:
: The PLCO trial adhered to the ethical standards outlined in the Declaration of Helsinki. The study protocol was approved by the Institutional Review Boards of all study centers and the National Cancer Institute (project number: PLCO-1442). Informed consent was obtained from all individual participants included in the trial.
: Not applicable.
: The authors declare no competing interests.
